Questions? Contact us.

sidebar-facebook

As experts in hemophilia care, we understand the importance and priority of your clotting factor medication—having your brand, in the right quantity, at the right dose, at right the place, at the right time and with the supplies you prefer. We carry all brands of clotting factor products, in all available assay sizes, and can ship them to you via express delivery anywhere in the United States. Moreover, our clinicians are available to assist you 24 hours per day, 7 days per week.

Factor I Products

  • RiaSTAP® [riastap.com]

    Class Human
    Distributor CSL Behring
    Route of administration Intravenous
    Indication For the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. Package Insert
    Assay sizes (mg) 900-1300
    Diluent size 50 ml
    Storage When stored at temperatures of 2-25°C (36-77°F), RiaSTAP is stable for the period indicated by the expiration date on the carton and vial label (up to 60 months). Do not freeze. Protect from light.
    Half-life 78.7 ± 18.13 hours

Factor VII Products

  • NovoSeven® RT [novosevenrt.com]

    Class Recombinant
    Distributor Novo Nordisk
    Indication Treatment of bleeding episodes in hemophilia A or B with inhibitors and in acquired hemophilia. Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B with inhibitors and in acquired hemophilia. Treatment of bleeding episodes in congenital FVII deficiency. Package Insert
    Vial Size 1, 2, 5, 8 mg
    Diluent Size 1.1, 2.1, 5.2, 8.1 ml
    Mixing Device MixPro™
    Room Temperature Storage Until product expiration
    Duration of Bypass Activity Approximately 2 hours
    Other websites mynovosecure.com

Factor VIII Products

  • Advate® [advate.com]

    Class Recombinant
    Distributor Baxalta
    Indication Control and prevention of bleeding episodes in adults and children with hemophilia A. Perioperative management in adults and children (0-16 years) with hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 1500, 2000, 3000, 4000
    Diluent Size 5.0 ml
    Mixing Device BAXJECT® III
    Room Temperature Storage 6 months
    Half-life 11.98 +/- 4.28
    Other websites baxaltahematology.com
  • Adynovate® [adynovate.com]

    Class Recombinant, PEGylated
    Distributor Baxalta
    Indication In adolescent and adult patients (12 years and older) with hemophilia A (congenital factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, and routine prophylaxis to reduce the frequency of bleeding episodes. Package Insert
    Assay sizes (IU) 250, 500, 1000, 2000
    Diluent size 5.0 ml
    Mixing device Baxject II® High Flow
    Room temperature storage Up to 1 month
    Half-life

    13.43 ± 4.05 hours (12 to <18 years), 14.69 ± 3.79 hours (≥18 years)

    Other websites baxaltahematology.com
  • Afstyla® [afstyla.com]

    Class Recombinant, Single Chain
    Distributor CSL Behring
    Indication In adults and children with hemophilia A (congenital Factor VIII deficiency) for on-demand treatment and control of bleeding episodes, routine prophylaxis to reduce the frequency of bleeding episodes, rerioperative management of bleeding. Package Insert
    Assay sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent size 2.5 ml (250 IU, 500 IU, 1000 IU), 5.0 ml (2000 IU, 3000 ml)
    Mixing device Mix2Vial®
    Room temperature storage Up to 3 months
    Half-life

    14.3 hours (12 to <18 years), 14.2 hours (≥18 years)

    Other websites mysourcecsl.com, cslbehring.com
  • Eloctate™ [eloctate.com]

    Class Recombinant, Fc Fusion Protein
    Distributor Biogen
    Indication Indicated in adults and children with hemophilia A (congenital Factor VIII deficiency) for control and prevention of bleeding episodes, perioperative management and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
    Assay Sizes (IU) 250, 500, 750, 1000, 1500, 2000, 3000
    Diluent Size 3.0 ml (pre-filled syringe)
    Mixing Device Vial adapter
    Room Temperature Storage 6 months
    Half-life 19.7 hours in adults
    Other websites biogen.com
  • Helixate® FS [helixatefs.com]

    Class Recombinant
    Distributor CSL Behring
    Indication Control and prevention of bleeding episodes and perioperative management in adults and children (0–16 years) with hemophilia A. Routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage.
    Assay Sizes (IU) 250, 500, 1000, 1500, 2000, 3000
    Diluent Size 2.5 ml (250 IU, 500 IU, 1000 IU), 5.0 (2000 IU, 3000 IU)
    Mixing Device Mix2Vial®
    Room Temperature Storage 12 months
    Half-life Approximately 13 hours
    Other websites mysourcecsl.com, cslbehring.com
  • Hemofil® M [baxaltahematology.com]

    Class Monoclonal
    Distributor Baxalta
    Indication Prevention and control of hemorrhagic episodes in hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 1700
    Diluent Size 10.0 ml
    Mixing Device Double-ended transfer needle
    Room Temperature Storage Until expiration
    Half-life 14.8 +/- 3.0
    Other websites baxaltahematology.com
  • Kogenate® FS [kogenatefs.com]

    Class Recombinant
    Distributor Bayer
    Indication Control and prevention of bleeding episodes and perioperative management in adults and children (0–16 years) with hemophilia A. Routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage. Perioperative management in adults and children with hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent Size 2.5 ml (250 IU, 500 IU, 1000 IU), 5.0 (2000 IU, 3000 IU)
    Mixing Device Double-ended transfer needle
    Room Temperature Storage 12 months
    Half-life 14.38 +/- 4.38 hours
    Other websites livingwithhemophilia.com, pharma.bayer.com
  • Kogenate® FS w/ BIO-SET® [kogenatefs.com]

    Class Recombinant
    Distributor Bayer
    Indication Control and prevention of bleeding episodes and perioperative management in adults and children (0–16 years) with hemophilia A. Routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage. Perioperative management in adults and children with hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent Size 2.5 ml (250 IU, 500 IU, 1000 IU), 5.0 (2000 IU, 3000 IU)
    Mixing Device BIO-SET®
    Room Temperature Storage 12 months
    Half-life 14.38 +/- 4.38 hours
    Other websites livingwithhemophilia.com, pharma.bayer.com
  • Kogenate® FS w/ Vial Adapter [kogenatefs.com]

    Class Recombinant
    Distributor Bayer
    Indication Control and prevention of bleeding episodes and perioperative management in adults and children (0–16 years) with hemophilia A. Perioperative management in adults and children with hemophilia A. Routine prophylaxis to reduce the frequency of bleeding episodes and the risk of joint damage in children with hemophilia A with no preexisting joint damage. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent Size 2.5 ml (250 IU, 500 IU, 1000 IU), 5.0 (2000 IU, 3000 IU)
    Mixing Device Vial Adapter
    Room Temperature Storage 12 months
    Half-life 14.38 +/- 4.38 hours
    Other websites livingwithhemophilia.com, http://pharma.bayer.com/
  • Kovaltry® [kovaltry-us.com]

    Class Recombinant
    Distributor Bayer HealthCare
    Indication For use in adults and children with hemophilia A (congenital factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. Package Insert
    Assay sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent size 2.5 ml pre-filled syringe (250 IU, 500 IU, 1000 IU), 5.0 ml pre-filled syringe (2000 IU, 3000 IU)
    Mixing device Vial adapter
    Room temperature storage Up to 12 months
    Half-life (chromogenic substrate assay)

    12.1 ± 2.7 hours (0 <6 years), 12.0 ± 2.1 hours (6 to <12 years), 14.4 ± 5.5 hours (children 12 to 17 years), 14.2 ± 3.5 hours (≥18 years)

    Other websites livingwithhemophilia.com, pharma.bayer.com
  • Monoclate-P® [CSLBehring.com]

    Class Monoclonal
    Distributor CSL Behring
    Indication Treatment of classical hemophilia (hemophilia A). Package Insert
    Assay Sizes (IU) 250, 500, 1000, 1500
    Diluent Size 2.5 ml (250 IU), 5.0 ml (500 IU), 10.0 ml (1000 IU), 10.0 ml (1500 IU)
    Mixing Device Double-ended transfer needle
    Room Temperature Storage 6 months
    Half-life 17.5 hours
    Other websites mysourcecsl.com, cslbehring.com
  • Novoeight® [novoeight.com]

    Class Recombinant
    Distributor Novo Nordisk
    Indication For use in adults and children with hemophilia A for: control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes. Package Insert
    Assay sizes (IU) 250, 500, 1000, 1500, 2000, 3000
    Diluent size 4.0 ml (pre-filled syringe)
    Mixing device Vial adapter
    Room temperature storage Up to 1 month
    Half-life

    7.7 to 9.1 hours (children 0 to <6 years), 8.0 to 8.5 hours (children 6 to <12 years), 10.8 to 12 hours (adults)

    Other websites mynovosecure.com
  • Nuwiq® [nuwiq.com]

    Class Recombinant, human
    Distributor Octapharma
    Indication In adults and children with hemophilia A, for on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000
    Diluent Size 2.5 ml (pre-filled syringe)
    Mixing Device Vial adapter
    Room Temperature Storage 3 months
    Half-life 17.1 ± 11.2 hours* (*Median, lower/upper quartile: 13.7, 12.0/17.5)
    Other websites octapharma.com
  • Recombinate® [recombinate.com]

    Class Recombinant
    Distributor Baxalta
    Indication Prevention and control of hemorrhagic episodes in hemophilia A. Perioperative management of patients with hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 1500, 2000
    Diluent Size 5.0 ml
    Mixing Device BAXJECT® II
    Room Temperature Storage Until expiration
    Half-life 14.6 +/- 4.9 hours
    Other websites baxaltahematology.com
  • Xyntha® [xyntha.com]

    Class Recombinant
    Distributor Pfizer
    Indication Control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000
    Diluent Size 4.0 ml (pre-filled syringe)
    Mixing Device R2 Kit
    Room Temperature Storage 3 months
    Half-life 8.03 +/- 2.44 hours
    Other websites hemophiliavillage.com, pfizerrxpathways.com,pfizer.com
  • Xyntha® w/ Dual Chamber Syringe [xyntha.com ]

    Class Recombinant
    Distributor Pfizer
    Indication Control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent Size 4.0 ml (pre-filled dual chamber syringe)
    Mixing Device Solofuse®
    Room Temperature Storage 3 months
    Half-life 8.03 +/- 2.44 hours
    Other websites hemophiliavillage.com, pfizerrxpathways.com,pfizer.com

Factor IX Products

  • Alphanine® SD [alphaninesd.com]

    Class Plasma-Derived
    Distributor Grifols
    Indication Prevention and control of bleeding in patients with Factor IX deficiency due to hemophilia B. Package Insert
    Assay Sizes (IU) 500, 1000, 1500
    Diluent Size 10.0 ml
    Mixing Device Mix2Vial®
    Room Temperature Storage 1 month
    Half-life 21 hours
    Other Websites hemophilia.upatient.com, grifolsusa.com
  • Alprolix™ [alprolix.com]

    Class Recombinant, Fc Fusion Protein
    Distributor Biogen Idec
    Indication Indicated in adults and children with hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
    Assay Sizes (IU) 500, 1000, 2000, 3000
    Diluent Size 5.0 ml (pre-filled syringe)
    Mixing Device Vial adapter
    Room Temperature Storage 6 months
    Half-life 86.52 hours (adults), 83.59 hours (adolescents 12 to 17)
    Other Websites biogen.com
  • BeneFix® [benefix.com]

    Class Recombinant
    Distributor Pfizer
    Indication Control and prevention of bleeding episodes in adult and pediatric patients with hemophilia B. Perioperative management in adult and pediatric patients with hemophilia B. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent Size 5.0 ml
    Mixing Device R2 Kit
    Room Temperature Storage 24 months
    Half-life 18.8 +/- 5.4 hours
    Other websites hemophiliavillage.com, pfizerrxpathways.com,pfizer.com
  • Idelvion® [idelvion.com]

    Class Recombinant, albumin fusion protein
    Distributor CSL Behring
    Indication In children and adults with hemophilia B (congenital Factor IX deficiency) for: on-demand control and prevention of bleeding episodes, perioperative management of bleeding, routine prophylaxis to prevent or reduce the frequency of bleeding episodes. Package Insert
    Assay sizes (IU) 250, 500, 1000, 2000
    Diluent size 2.5 ml (250 IU, 500 IU, 1000 IU), 5.0 ml (2000 IU)
    Mixing device Mix2Vial®
    Room temperature storage Yes
    Half-life (following a single 50 IU/kg dose) 90 hours (0 <6 years), 93 hours (6 to <12 years), 87 hours (children 12 to <18 years), 104 hours (≥18 years)
    Other websites mysourcecsl.com, cslbehring.com
  • Ixinity® [ixinity.com]

    Class Recombinant
    Distributor Emergent BioSolutions
    Indication In adults and children ≥ 12 years of age with hemophilia B for control and prevention of bleeding episodes, and for perioperative management. Package Insert
    Assay sizes (IU) 500, 1000, 1500
    Diluent size 5.0 ml (pre-filled syringe)
    Mixing device Vial adapter
    Room temperature storage Yes
    Half-life 24 ± 7 hours
    Other websites emergentbiosolutions.com
  • Mononine® [CSLBehring.com]

    Class Monoclonal
    Distributor CSL Behring
    Indication For the prevention and control of bleeding in Factor IX deficiency. Package Insert
    Assay Sizes (IU) 500, 1000
    Diluent Size 5.0 ml (500 IU), 10.0 ml (1000 IU)
    Mixing Device Double-ended transfer needle
    Room Temperature Storage 1 month
    Half-life 22.6 to 25.3 hours
    Other websites mysourcecsl.com, cslbehring.com
  • Rixubis™ [rixubis.com]

    Class Recombinant
    Distributor Baxalta
    Indication Control and prevention of bleeding episodes, perioperative management, and routine prophylaxis in adults and children with hemophilia. Package Insert
    Assay Sizes (IU) 250, 500, 1000, 2000, 3000
    Diluent Size 5.0 ml
    Mixing Device BAXJECT® II
    Room Temperature Storage 6 months
    Half-life 25.4 +/- 6.9
    Other websites baxaltahematology.com

Factor X Products

  • Coagadex® [coagadex.com]

    Class Human
    Distributor Bio Products Laboratory (BPL)
    Indication In adults and children (aged 12 years and above) with hereditary factor X deficiency for on-demand treatment and control of bleeding episodes, and perioperative management of bleeding in patients with mild hereditary factor X deficiency.
    Assay Sizes (IU) 250, 500
    Diluent Size 2.5 ml (250 IU), 5.0 ml (500 IU)
    Mixing Device Mix2Vial®
    Storage Store the coagadex package in a refrigerator or at room temperature (36°F to 86°F). Do not freeze. Do not use coagadex or the sterile water for injection after the expiration date printed on the vial 365 and carton labels. The expiration date refers to the last day of that month.
    Half-life 30.3 hours
    Patient assistance program mycoagadex.medmonk.com
    Other websites factorXinfo.com

FVIII/VWF Products

  • Alphanate® [alphanate.com]

    Class Plasma-Derived
    Distributor Grifols
    Indication Control and prevention of bleeding in patients with Factor VIII deficiency due to hemophilia A. Surgical and/or invasive procedures in adult and pediatric patients with von Willebrand disease (vWD) in whom desmopressin (DDAVP) is either ineffective or contraindicated. It is not indicated for patients with severe vWD (Type 3) undergoing major surgery. Package Insert
    Assay Sizes (IU) FVIII: 250, 500, 1000, 1500, 2000
    Diluent Size 5.0 ml (250 IU FVIII, 500 IU FVIII), 10.0 ml (1000 IU FVIII, 1500 IU FVIII)
    Mixing Device Mix2Vial®
    Room Temperature Storage 36 months
    Other Websites hemophilia.upatient.com, findthe2percent.com,grifolsusa.com
  • Humate-P® [humate-p.com]

    Class Plasma-Derived
    Distributor CSL Behring
    Indication Hemophilia A – Treatment and prevention of bleeding in adults. Von Willebrand disease (vWD) – in adults and pediatric patients in the (i) treatment of spontaneous and trauma-induced bleeding episodes; it is not indicated for the prophylaxis of spontaneous bleeding episodes, and (ii) prevention of excessive bleeding during and after surgery. This applies to patients with severe vWD as well as patients with mild to moderate vWD where the use of desmospressin is known or suspected to be inadequate.Package Insert
    Assay Sizes (IU) FVIII – 250, 500, 1000; VWF:RCo – 600, 1200, 2400
    Diluent Size 5.0 ml (250 IU FVIII, 600 IU VWF:RCo), 10.0 ml (500 IU FVIII, 1200 IU VWF:RCo), 15.0 ml (1000 IU FVIII, 2400 IU VWF:RCo)
    Mixing Device Mix2Vial®
    Room Temperature Storage 24 months
    Half-life Mean 12.2 hours (FVIII), Median 11.0 hours (VWF:RCo)
    Other websites mysourcecsl.com, cslbehring.com
  • Koāte®-DVI [koate-dviusa.com]

    Class Plasma-Derived
    Distributor Kedrion Biopharma
    Indication Treatment of hemophilia A in which there is a demonstrated deficiency of activity of the plasma clotting factor, factor VIII. Koāte-DVI provides a means of temporarily replacing the missing clotting factor in order to control or prevent bleeding episodes, or in order to perform emergency and elective surgery on individuals with hemophilia. Koāte-DVI contains naturally occurring von Willebrand factor, which is co-purified as part of the manufacturing process. Package Insert
    Assay Sizes (IU) FVIII: 250, 500, 1000
    Diluent Size 5.0 ml (250 IU FVIII, 500 IU FVIII), 10.0 ml (1000 IU FVIII)
    Mixing Device Mix2Vial®
    Room Temperature Storage 6 months
    Half-life Mean 16.12 hours (FVIII)
    Other websites kedrionusa.com
  • Wilate® [wilateusa.com]

    Class Plasma-Derived
    Distributor Octapharma
    Indication In children and adults with von Willebrand disease for: on-demand treatment and control of bleeding episodes, and perioperative management of bleeding. Package Insert
    Assay Sizes (IU) FVIII: 500, 1000; RCo: 500, 1000
    Diluent Size 5.0 ml (500 IU FVIII, 500 IU VWF:RCo), 10.0 ml (1000 IU FVIII, 1000 IU VWF:RCo)
    Mixing Device Mix2Vial®
    Room Temperature Storage 6 months
    Half-life Mean 19.6 ± 6.9 (FVIII), Mean 15.8 ± 11.0 (VWF:RCo)
    Other websites octapharma.com

Factor XIII Deficiency

  • Corifact® [corifact.com]

    Class Human
    Distributor CSL Behring
    Indication Routine prophylactic treatment of congenital Factor XIII (FXIII) deficiency. Package Insert
    Assay Sizes (IU) 1000–1600
    Diluent Size 20 ml (1000–1600)
    Mixing Device Mix2Vial®
    Storage Up to 6 months
    Half-life 6.6 ± 2.29 days
    Other websites mysourcecsl.com, cslbehring.com
  • Tretten® [tretten-us.com]

    Class Recombinant
    Distributor Novo Nordisk
    Route of Administration Intravenous
    Indication Tretten® (coagulation factor XIII A-subunit [recombinant]) is indicated for routine prophylaxis of bleeding in patients with congenital factor XIII A-subunit deficiency. Package Insert
    Assay sizes (IU) 2000–3125
    Diluent size 3.2 ml
    Mixing device Vial adapter
    Storage Store refrigerated at 2–8°C (36–46°F) prior to reconstitution. Tretten is stable until the expiration date on the carton and vial label. Do not freeze. Store protected from light.
    Half-life 5.1 (± 2.6) days
    Other websites mynovosecure.com

Inhibitor Products

  • FEIBA® NF [feiba.com]

    Class Plasma-derived
    Distributor Baxalta
    Indication Control of spontaneous bleeding episodes or to cover surgical interventions in hemophilia A and hemophilia B patients with inhibitors. Clinical experience suggests that patients with factor VIII inhibitor titer of less than 5 BU may be successfully treated with antihemophilic factor. Patients with titers ranging between 5 and 10 BU may either be treated with antihemophilic factor or FEIBA NF. Cases with factor VIII inhibitor titers greater than 10 BU have generally been refractory to treatment with antihemophilic factor. Package Insert
    Vial Size 500, 1000, 2500 Units
    Diluent Size 20 ml or 50 ml
    Mixing Device BAXJECT® II
    Room Temperature Storage Until product expiration
    Duration of Bypass Activity 8 to 12 hours
    Other websites baxaltahematology.com

Twitter